secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001493152-25-025966
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa director Robert Finizio resigns from board effective Dec 2, 2025
------------------------------------------------------------------------

- Independent director Robert G. Finizio resigned as board member, Compensation Committee chair, and Audit Committee member.
- Resignation effective immediately on December 2, 2025; accepted by the Board.
- Resignation was for personal reasons, not due to any disagreement with the Company on operations, policies, or practices.
- No replacement has been announced for the vacated board or committee positions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225025966/0001493152-25-025966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225025966/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer